As Lilly and BMS invest in manufacturing, demand for drugs still outweighs supply

As Lilly and BMS invest in manufacturing, demand for drugs still outweighs supply

Source: 
Pharma Voice
snippet: 

From popular weight loss drugs to lifesaving cancer therapies, recent pharma deals show the industry is doubling down on manufacturing capacity to meet demand.